000			01439 a2200385 4500
005			20250512024834.0
264		0	_c19890505
008			198905s 0 0 eng d
022			_a0027-8424
024	7		_a10.1073/pnas.86.7.2483 _2doi
040			_aNLM _beng _cNLM
100	1		_aNishino, S
245	0	0	_aProstaglandin E2 and its methyl ester reduce cataplexy in canine narcolepsy. _h[electronic resource]
260			_bProceedings of the National Academy of Sciences of the United States of America _cApr 1989
300			_a2483-7 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, U.S. Gov't, P.H.S.
650	0	4	_aAnimals
650	0	4	_aBlood Pressure _xdrug effects
650	0	4	_aBody Temperature _xdrug effects
650	0	4	_aCataplexy _xdrug therapy
650	0	4	_aDinoprostone _xanalogs & derivatives
650	0	4	_aDog Diseases _xphysiopathology
650	0	4	_aDogs
650	0	4	_aHeart Rate _xdrug effects
650	0	4	_aMotor Activity _xdrug effects
650	0	4	_aNarcolepsy _xphysiopathology
650	0	4	_aReference Values
650	0	4	_aSleep _xdrug effects
700	1		_aMignot, E
700	1		_aFruhstorfer, B
700	1		_aDement, W C
700	1		_aHayaishi, O
773	0		_tProceedings of the National Academy of Sciences of the United States of America _gvol. 86 _gno. 7 _gp. 2483-7
856	4	0	_uhttps://doi.org/10.1073/pnas.86.7.2483 _zAvailable from publisher's website
999			_c2934188 _d2934188